CA-CAVLI-WIRELESS
26.3.2024 10:21:33 CET | Business Wire | Press release
Cavli Wireless, a pioneer in the IoT solutions landscape, is all set to announce its flagship 5G RedCap CQM220 Cellular IoT Module at Embedded World 2024. The event, held at the NürnbergMesse GmbH, Nürnberg, Germany, from April 9 to 11 in Hall 3, Booth 3-311. Embedded World event is known for being the largest trade fair for Embedded technology, showcasing the latest and greatest in electronic systems, distributed intelligence, IoT, energy efficiency, and more. The event represents the premier stage for global innovators like Cavli Wireless to showcase the innovative CQM220 to the world.
The CQM220 is the flagship 5G RedCap cellular IoT module from Cavli Wireless, compatible with 3GPP release 17 standards, specifically designed for advanced IoT and M2M applications. It delivers robust data bandwidth, reaching up to 226Mbps in downlink and 121Mbps in uplink, facilitating rapid and efficient data transfer. Available in LGA, PCIe Gen2, and M.2 form factors, the CQM220 ensures broad compatibility and flexibility across various industrial applications. Its optional integrated eSIM offers global connectivity through the Cavli Hubble Device and Connectivity management platform, making it a versatile solution for international deployment.
Moreover, the CQM220's optional integrated GNSS feature positions it as an ideal candidate for precise tracking applications, essential in sectors like Asset Tracking and Vehicular Telemetry Systems. Accompanied by a Linux-based OpenSDK, the module allows for application-specific coding directly on the device, eliminating the need for an external host MCU. This capability, combined with its high data throughput and global operability, makes the CQM220 an optimal choice for next-generation applications that demand speed, accuracy, and worldwide functionality.
The CQM220 module is set to supercharge a range of industries with its advanced connectivity. In Industry 4.0, the module's high data throughput, and integrated GNSS make it a linchpin for smart factories, facilitating real-time monitoring and control of machinery, and predictive maintenance, thereby enhancing efficiency and reducing downtime. For Smart City initiatives, the CQM220's global connectivity and robust bandwidth support the deployment of smart grids, intelligent transportation systems, and public safety networks, contributing to more efficient and responsive urban environments. In asset tracking, the precision of the integrated GNSS and the module's widespread connectivity ensure accurate, real-time location tracking of goods and equipment across borders, which is crucial for logistics, fleet management, and theft prevention. Across these applications, the CQM220 empowers industries to harness the full potential of seamless global connectivity, driving innovation and operational excellence.
The Cavli Hubble Stack further enhances the capabilities of the CQM220 by introducing remote diagnosis, monitoring, and debugging of the module through Hubble Lens, an advanced component of the Cavli Hubble IoT connectivity & modem management platform. This feature eliminates the necessity for physical intervention, simplifying the expansion of IoT solutions. Through strategic alliances with operators worldwide, Cavli has established a substantial presence, delivering unparalleled connectivity solutions that set new standards in service quality and cost-effectiveness.
John Mathew, the CEO and the Chief Technology Architect of Cavli Wireless, remarked, "Unveiling the CQM220 at Embedded World 2024 marks a pivotal point for our company. Our continuous commitment to superior performance and creativity in the field of intelligent cellular connections has culminated in the creation of this durable 5G RedCap module. It is characterized by its dependability, effectiveness, and the ability to provide uninterrupted connectivity worldwide. These features are the core aspects of the CQM220 and serve to set apart both the product and Cavli Wireless in the bustling market."
With the unveiling of the CQM220 at Embedded World 2024, Cavli Wireless reiterates its dedication to providing cost-effective, uninterrupted, and superior cellular IoT solutions. We encourage you to engage with our solution specialists to explore the ways the CQM220 can enhance your upcoming project. Embark on your path to dependable and effective connectivity with Cavli.
About Cavli Wireless
Cavli Wireless is a cellular IoT module manufacturer that combines IoT connectivity and data management into one platform. Cavli designs and manufactures industrial-grade cellular IoT smart modules that improve equipment reliability and expedite application development processes. Cavli's smart cellular modules are equipped with global cellular connectivity through integrated eSIM functionality that provides users with affordable global data pricing, simplified device management, and centralized subscription management through the proprietary cloud-based platform Cavli Hubble.
About Embedded World
The Embedded World Exhibition & Conference is a global platform for the embedded systems community, where professionals from around the world can connect and share knowledge. The event offers insights into the entire world of embedded systems, including hardware, software, tools, and services. It features a high-quality transfer of knowledge through top-class speakers, expert panels, and exhibitor forums.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240326234488/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom